Next-gen Novo Nordisk shot shows 22% weight loss in early results
One of Novo Nordisk's next-generation obesity shots to follow up on its success with Wegovy helped patients lose 22% of their ...
Investors Bet Trump Will Make Europe Investable Again
The big hope is that Europe will move faster to implement reforms in the face of competitive threats from the U.S.
STAT35m
Novo Nordisk’s next-generation obesity treatment shows promise in early study
A new weight loss drug from Novo Nordisk helped patients lose a large amount of weight, providing a boost for Novo in the ...
Novo Nordisk Shares Surge on New Obesity Drug Results — Update
The trial tested amycretin in its injectable form, but Novo Nordisk is also separately developing the drug in pill form. Investors cheered an early trial of the pill early last year that showed weight ...
Copenhagen Post39m
New results from weight-loss drug boost Novo’s stock value
New data from a study on Novo Nordisk’s weight-loss drug, amycretin, has shown positive results. Participants in the study who received the highest dose of the drug lost an average of 22 percent of ...
There could be a new definition for obesity. A doctor explains why this matters
A commission proposed a new definition of obesity focused on how excess fat affects the body, rather than assessing body mass ...